Pulmonary pathology in thyroid transcription factor-1 deficiency syndrome

Csaba Galambos1, Hara Levy, Carolyn L Cannon

  • 1Department of Pathology, Children's Hospital Boston, Massachusetts 02115, USA.

Insights

Thyroid transcription factor-1 (TTF-1) deficiency causes severe respiratory issues due to abnormal lung development and surfactant production. This case highlights TTF-1

Area of Science:

  • Genetics and Developmental Biology
  • Pulmonology
  • Pediatric Pathology

Background:

  • Thyroid transcription factor-1 (TTF-1) deficiency syndrome presents with neurological, thyroid, and pulmonary issues, often leading to respiratory failure in children.
  • TTF-1 is crucial for lung development and surfactant production, but its role in haploinsufficiency syndromes is not fully understood.

Observation:

  • A case study of an infant with a 14q12-21.3 haploid deletion encompassing the TTF-1 gene locus, presenting with cerebral dysgenesis, thyroid dysfunction, and respiratory insufficiency.
  • The infant experienced hyaline membrane disease, required continuous ventilatory support, and exhibited pulmonary cysts, ultimately succumbing to pneumonia and respiratory failure at 8 months.
  • Pathological examination revealed emphysematous changes, diminished airway generations, reduced radial alveolar count, alveolar fibrosis, pneumocyte hypertrophy, and altered surfactant protein expression.

Findings:

  • The infant's lungs showed abnormal airway and alveolar morphogenesis, with diminished airway branching and alveolar development.
  • Ultrastructural analysis indicated alterations in type II pneumocytes and surfactant metabolism, with diminished SP-A and ABCA3 but robust SP-B and proSP-C expression.
  • These pulmonary findings correlate with the TTF-1 haploinsufficiency, suggesting a critical role for TTF-1 in lung development and surfactant homeostasis.

Implications:

  • This case underscores the significant impact of TTF-1 haploinsufficiency on pulmonary development and function, contributing to severe respiratory distress.
  • The findings provide insights into the pathogenesis of respiratory failure in TTF-1 deficiency syndromes and highlight the importance of TTF-1 in surfactant metabolism.
  • Understanding these mechanisms can inform future diagnostic and therapeutic strategies for infants with similar genetic conditions affecting lung development.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...